Depolymerized products of λ-carrageenan as a potent angiogenesis inhibitor

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 17, 2007, Pages 6910-6917

  Chen, Haimin ^a   Yan, Xiaojun ^a   Lin, Jing ^c   Wang, Feng ^b   Xu, Weifeng ^b  

^a NINGBO UNIVERSITY   (China)

^b Lihuili Hospital   (China)

^c NONE

Author keywords

carrageenan; Angiogenesis; Chick chorioallantoic membrane; Human umbilical vein endothelial cells; Oligosaccharides

Indexed keywords

ANGIOGENESIS INHIBITOR; CARRAGEENAN; POLYMER;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CHEMISTRY; CHICKEN; CHORIOALLANTOIS; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; TUMOR CELL LINE; UMBILICAL VEIN; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CARRAGEENAN; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHICKENS; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; HUMANS; POLYMERS; UMBILICAL VEINS;

EID: 34548312355     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf070183+     Document Type: Article

References (44)

1. Bar-Ner, M.; Eldor, A.; Wasserman, L.; Matzner, Y.; Cohen, I. R.; Fuks, Z.; Vlodavsky, I. Inhibition of heparanase mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood 1987, 70, 551-557.
2. Irimura, T.; Nakajima, M.; Nicolson, G. L. Chemically modified heparins as inhibitors of heparan sulfate specific endo-β-glucuronidase (heparanase) of metastatic melanoma cells. Biochemistry 1986, 25, 5322-5328.
3. Miao, H. Q.; Elkin, M.; Aingorn, E.; Ishai-Michaeli, R.; Stein, C. A.; Vlodavsky, I. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int. J. Cancer 1999, 83, 424-431.
4. Saiki, I.; Murata, J.; Nakajima, M.; Tokura, S.; Azuma, I. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res. 1990, 50, 3631-3637.
5. Pantoliano, M. W.; Horlick, R. A.; Springer, B. A.; Van Dyk, D. E.; Tobery, T.; Wetmore, D. R.; Lear, J. D.; Nahapetian, A. T.; Bradley, J. D.; Sisk, W. P. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994, 33, 10229-10248.
6. Fan, T. P.; Jaggar, R.; Bicknell, R. Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci. 1995, 16, 57-66.
7. Parish, C. R.; Coombe. D. R.; Jakobsen, K. B.; Bennett, F. A.; Underwood, P. A. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases. Int. J. Cancer 1987, 40, 511-518.
8. Stringer, S. E.; Gallagher, J. T. Heparan Sulphate. Int. J. Biochem. Cell Biol. 1997, 29, 709-714.
9. Sweeney, M. D.; Yu, Y. H.; Leary, J. A. Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 2006, 17, 1114-1119.
10. Presta, M.; Leali, D.; Stabile, H.; Ronca, R.; Camozzi, M.; Coco, L.; Moroni, E.; Liekens, S.; Rusnati, M. Heparin derivatives as angiogenesis inhibitor. Curr. Pharm. Des. 2003, 9, 533-566.
11. Ji, M. H. Carrageenan. In Seaweed Chemistry, 3rd ed.; Ji, M. H., Eds.; Science Press: Beijing, China, 1997; pp 123-124.
12. Santos, G. A. Carrageenans of species of Eucheuma J. Agardh and Kappaphycus Doty (Solieriaceae, Rhodophyta). Aquat. Bot. 1989, 36, 55-67.
13. Mclean, W. M.; Williamson, F. B. kappa-Carrageenan from Pseudomonas carrageenovora. Eur. J. Biochem. 1979, 93, 553-558.
14. Opoku, G.; Qiu, X. D.; Doctor, V. Effect of oversulfation on the chemical and biological properties of kappa carrageenan. Carbohydr. Polym. 2006, 65, 134-138.
15. Hoffman, R.; Burns, W. W.; Paper, D. H. Selective inhibition of cell proliferation and DNA synthesis by the polysulphated carbohydrate ι-carrageenan. Cancer Chemother. Pharmacol. 1995, 36, 325-334.
16. Talarico, L. B.; Pujol, C. A.; Zibetti, R. G. M.; Faria, P. C. S.; Noseda, M. D.; Duarte, M. E. R.; Damonte, E. B. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res. 2005, 66, 103-110.
17. Girond, S.; Crance, J. M.; Vancuyckgandre, H.; Renaudet, J.; Deloince, R. Antiviral activity of carrageenan on hepatitis A virus replication in cell culture. Res. Virol. 1991, 142, 261-270.
18. Lindahl, U.; Kusche-Gullberg, M.; Kjellen, L. Regulated diversity of heparan sulfate. J. Biol. Chem. 1998, 273, 24979-24982.
19. Lander, A. D.; Selleck, S. B. The elusive functions of proteoglycans: in vivo Veritas. J. Cell Biol. 2000, 148, 227-232.
20. Yamada, T.; Ogamo, A.; Saito, T.; Watanabe, J.; Uchiyama, H.; Nakagawa, Y. Preparation and anti-HIV activity of low-molecular weight carrageenans and their sulfated derivatives. Carbohydr. Polym. 1997, 32, 51-55.
21. Coombe, D. R.; Parish, C. R.; Ramshaw, I. A. Analysis of the inhibition of tumor metastasis by sulphated polysaccharides. Int. J. Cancer 1987, 39, 82-88.
22. Noda, H.; Amano, H.; Arashima, K.; Hashimoto, S.; Nisizawa, K. Studies on the antitumor activity of marine algae. Nippon Suisan Gakkaishi 1989, 55, 1259-1264.
23. Zhou, G. F.; Sun, Y. P.; Xin, H.; Zhang, Y. N.; Li, Z. E.; Xu, Z. H. In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol. Res. 2004, 50, 47-53.
24. Kirchner, L. M.; Schmidt, S. P.; Gruber, B. S. Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis. Microvasc. Res. 1996, 51, 2-14.
25. Holownia, A.; Braszko, J. J. Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4. Biochem. Pharmacol. 2004, 67, 1057-1064.
26. Eubank, T. D.; Galloway, M.; Montague, C. M.; Waldman, W. J.; Marsh, C. B. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J. Immunol. 2003, 171, 2637-2643.
27. Vincent, L.; Chen, W. M.; Hong, L.; Mirshahi, F.; Mishal, Z.; Mirshahi-Khorassani, T.; Vannier, J.; Soria, J.; Soria, C. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett. 2001, 495, 159-166.
28. Schlatter, P.; Konig, M. F.; Karlsson, L. M.; Burri, P. H. Quantitative study of intussusceptive capillary growth in the chorioallantoic membrane of the chicken embryo. Microvasc. Res. 1997, 54, 65-73.
29. Kyung-No, S.; Jungsu, H.; Byoung, S. K.; Jiyoung, K. Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells. Biochem. Biophys. Res. Commun. 2006, 340, 498-504.
30. Nakajima, M.; Irimura, T.; Nicolson, G. L. Heparanases and tumor metastasis. J. Cell Biochem. 1988, 36, 157-167.
31. Kosir, M. A.; Quinn, C. C. V.; Zukowski, K. L.; Grignon, D. J.; Ledbetter, S. Human prostate carcinoma cells produce extracellular heparanase. J. Surg. Res. 1997, 67, 98-105.
32. Auerbach, R.; Auerbach, W.; Polakowski, I. Assays for angiogenesis: A review. Pharmacol. Ther. 1991, 51, 1-11.
33. Ribatti, D.; Nico, B.; Vacca, A. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and antiangiogenesis in vivo. Anat. Rec. 2001, 264, 317-324.
34. Maccarana, M.; Casu, B.; Lindahl, U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 1993, 268, 23898-23905.
35. Kasbauer, C. W.; Paper, D. H.; Franz, G. Sulfated β-(1-4)-galacto- oligosaccharides and their effect on angiogenesis. Carbohydr. Res. 2001, 330, 427-430.
36. Hoffman, R.; Paper, D. H. Carrageenans: novel, selective growth factor antagonists with anti-proliferative activity. Br. J. Cancer 1993, 68, 442-443.
37. Paper, D. H.; Vogl, H.; Franz. G.; Hoffman, R. Defined carrageenan derivatives as angiogenesis inhibitors. Macromol. Symp. 1995, 99, 219-225.
38. Nakajima, M.; Dechavigny, A.; Johnson, C. E.; Hamada, J.; Stein, C. A.; Nicolson, G. L. Suramin. A potent inhibitor of melanoma heparanase and invasion. J. Biol. Chem. 1991, 266, 9661-9666.
39. Benezra, M.; Vlodavsky, I.; Yayon, A.; Bar-shavit, R.; Regan, J.; Chang, M.; Ben-sasson, S. Reversal of basic-fibroblast-growth-factor mediated autocrine-cell transformation by aromatic anionic compounds. Cancer Res. 1992, 52, 5656-5662.
40. Bürgermeister, J.; Paper, D. H.; Vogl, H.; Linhardt, R. J. LaPSvS1, a (1→3)-β-galactan sulfate and its effect on angiogenesis in vivo and in vitro. Carbohydr. Res. 2002, 337, 1459-1466.
41. Ishida, K.; Wierzba, M. K.; Teruya, T.; Simizu, S.; Osada, H. Novel heparin sulfate mimetic compounds as antitumor agents. Chem. Biol. 2004, 11, 367-377.
42. Gingras, D.; Bousquet-Gagnon, N.; Langois, S.; Lachambre, M. P.; Annabi, B.; Beliveau, R. Activation of the extracellular signal regulated signal-regulated protein kinase (ERK) cascade by membrane type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 2001, 507, 231-236.
43. Seiki, M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003, 194, 1-11.
44. Robinet, A.; Fahem, A.; Cauchard, J. H.; Huet, E.; Vincent, L.; Lorimier, S.; Antonicelli, F.; Soria, C.; Crepin, M.; Hornebeck, W.; Bellon, G. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J. Cell Sci. 2005, 118 (Pt 2), 343-356.